Microparticles (MPs) are a novel mediator and/or biomarker of cardiovascular disease (CVD) and type 2 diabetes. A high fat meal can elevate MP release in relation to CVD risk, but the effects of carbohydrates are unknown. This is clinically relevant as low-fat diets are advised for glycemic control. We tested the hypothesis that a 75g oral glucose tolerance test (OGTT) would promote changes in MPs linked to CVD risk. Twenty-five obese adults (Age: 52.4±3.2y, BMI: 32.5±1.2kg/m2) were screened for prediabetes using ADA criteria (75g OGTT and/or HbA1c). Eight were normal glucose tolerant (NGT) and 17 had prediabetes (PD). Body composition (bioelectrical impedance) was measured and arterial stiffness (augmentation index; AI), insulin and glucose were collected at 0 and 2 hour of the OGTT to assess CVD risk. Annexin V+ (AV+) and Annexin V- (AV-) total MPs and platelet MPs (CD31+/CD41+; CD41+) were also collected at these times and analyzed from fresh plasma via imaging flow cytometry. There were no statistical differences in age, BMI, or body fat (all P>0.21) between NGT and PD, although fasting and 2 hour glucose as well as insulin were higher in PD vs. NGT (P<0.03). Glucose and insulin increased during the OGTT (both P≤0.005), while arterial stiffness at 2 hour decreased by 6.9% (P=0.06). Fasting MPs were not different between groups. Total MPs, AV+ CD41+ and AV+ CD31+/CD41+ MPs decreased after the OGTT (P≤0.04), while AV- CD41+ (P=0.08) and CD31+/CD41+ (P=0.10) trended. Attenuated OGTT insulin responses were related to lower post-prandial platelet AV- CD31+/CD41- (r=0.46, P=0.06) and AV- CD41+ (r=0.45, P=0.06) MPs, while arterial stiffness was associated with reduced total MPs (r=-0.49, P=0.03) and AV+CD41+ (r=-0.52, P=0.02). An oral glucose load lowers post-prandial total and platelet MPs in obese adults with NGT and PD. Further work is required to examine MP content in order to gain mechanistic insight for optimizing type 2 diabetes management.


N. Eichner: None. N.M. Gilbertson: None. L. Musante: None. S. La Salvia: None. E. Barrett: None. A. Weltman: None. U. Erdbruegger: None. S.K. Malin: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.